Moderna Inc (MRNA)
106.19
-2.66
(-2.44%)
USD |
NASDAQ |
Apr 25, 16:00
105.67
-0.52
(-0.49%)
After-Hours: 20:00
Moderna Free Cash Flow: -3.825B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -3.825B |
September 30, 2023 | -2.657B |
June 30, 2023 | -754.00M |
March 31, 2023 | 612.00M |
December 31, 2022 | 4.581B |
September 30, 2022 | 6.201B |
June 30, 2022 | 9.215B |
March 31, 2022 | 13.03B |
December 31, 2021 | 13.34B |
September 30, 2021 | 11.39B |
June 30, 2021 | 9.083B |
Date | Value |
---|---|
March 31, 2021 | 5.007B |
December 31, 2020 | 1.959B |
September 30, 2020 | 612.84M |
June 30, 2020 | -374.97M |
March 31, 2020 | -451.14M |
December 31, 2019 | -491.00M |
September 30, 2019 | -489.50M |
June 30, 2019 | -482.04M |
March 31, 2019 | -445.20M |
December 31, 2018 | -436.63M |
Free Cash Flow Range, Past 5 Years
-3.825B
Minimum
Dec 2023
13.34B
Maximum
Dec 2021
3.447B
Average
612.84M
Median
Sep 2020
Free Cash Flow Benchmarks
Merck & Co Inc | 9.143B |
Pfizer Inc | 4.793B |
Eli Lilly and Co | -3.152B |
Johnson & Johnson | 17.78B |
Novavax Inc | -772.77M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 622.00M |
Cash from Investing (Quarterly) | -538.00M |
Cash from Financing (Quarterly) | -109.00M |
Free Cash Flow Per Share (Quarterly) | 1.052 |
Free Cash Flow to Equity (Quarterly) | 402.00M |
Free Cash Flow to Firm (Quarterly) | 402.00M |
Free Cash Flow Yield | -9.30% |